Search

everythinglearnresearchcommunity

for

Search:↓

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Finasteride works better for hair loss in patients 26 or younger.

Lespedeza cuneata extract may help treat enlarged prostate.

Finasteride effectively reduces symptoms of enlarged prostate with minimal side effects.

Dutasteride reduces DHT more effectively than finasteride.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Finasteride reduces prostate size and symptoms with few side effects.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Finasteride treats hair loss but may affect prostate cancer detection.

The healthcare for transgender veterans could be better with a more unified team approach.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.